USD 1.13
(-13.08%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | - | - | - | - |
Cost of Revenue | - | 527.00 | 768.62 | 451.71 |
Gross Profit | - | -527.00 | -768.62 | -451.71 |
Operating Expenses | 2.96 Million | 1.71 Million | 283.61 Thousand | 1.51 Million |
Selling, General and Administrative Expenses | 2.37 Million | 1.5 Million | 272.67 Thousand | 1.51 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | 584.82 Thousand | 210.5 Thousand | 10.94 Thousand | 2133.85 |
Cost and Expenses | 2.96 Million | 1.71 Million | 284.38 Thousand | 1.51 Million |
Operating Income | -2.96 Million | -1.71 Million | -174.44 Thousand | -1.4 Million |
Interest Expense | - | 183.21 Thousand | - | - |
Income Tax Expense | 205.37 | -648.9 Thousand | 109.94 Thousand | 110.22 Thousand |
Earnings before Tax | -5.3 Million | -1.06 Million | -394.33 Thousand | -1.62 Million |
Net Income | -5.3 Million | -419.48 Thousand | -504.27 Thousand | -1.73 Million |
Earnings Per Share Basic | -0.40 | -0.03 | -0.04 | -0.14 |
Earnings Per Share Diluted | -0.40 | -0.03 | -0.04 | -0.14 |
Weighted Average Shares Outstanding | 13.27 Million | 12.78 Million | 12.51 Million | 12.78 Million |
Weighted Average Shares Outstanding (Diluted) | 13.27 Million | 12.78 Million | 12.51 Million | 12.78 Million |
Gross Margin | - | - | - | - |
EBIT Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA | -2.37 Million | -1.87 Million | -176.65 Thousand | -2.88 Million |
Earnings Before Tax Margin | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 612.00 | 246.00 | - | 88.00 | 89.00 | 89.00 |
Gross Profit | -612.00 | -246.00 | - | -88.00 | -89.00 | -89.00 |
Operating Expenses | 717.01 Thousand | 881.68 Thousand | 5.95 Million | 803.28 Thousand | 420.32 Thousand | 425.34 Thousand |
Selling, General and Administrative Expenses | 717.01 Thousand | 881.68 Thousand | - | 803.28 Thousand | 357.27 Thousand | 387.96 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 717.62 Thousand | 881.93 Thousand | 5.95 Million | 803.37 Thousand | 420.41 Thousand | 425.43 Thousand |
Operating Income | -717.63 Thousand | -881.93 Thousand | -5.36 Million | -803.37 Thousand | -420.41 Thousand | -425.43 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -2.00 | 150.00 | 205.37 | 2.00 | -128.3 Thousand | 155.00 |
Earnings before Tax | -615.12 Thousand | -775.51 Thousand | -5.3 Million | -1.7 Million | -292.11 Thousand | -1.51 Million |
Net Income | -615.12 Thousand | -775.66 Thousand | -5.3 Million | -1.7 Million | -292.11 Thousand | -1.51 Million |
Earnings Per Share Basic | -0.05 | -0.06 | - | -0.13 | -0.02 | -0.11 |
Earnings Per Share Diluted | -0.05 | -0.06 | - | -0.13 | -0.02 | -0.11 |
Weighted Average Shares Outstanding | 13.27 Million | 13.27 Million | 13.27 Million | 13.27 Million | 13.27 Million | 13.27 Million |
Weighted Average Shares Outstanding (Diluted) | 13.27 Million | 13.27 Million | 13.27 Million | 13.27 Million | 13.27 Million | 13.27 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -717.02 Thousand | -881.68 Thousand | - | -803.28 Thousand | -418.56 Thousand | 802.07 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
AMAT
SJVN
MEEC
GUFICBIO
002790
LSPK